US-headquartered international specialty insurer Markel has secured acceptances for 19.6 percent of the stock of its intended M&A target Alterra, according to the latest Securities and Exchange Commission filing relating to the proposed deal.
US-headquartered international specialty insurer Markel has secured acceptances for 19.6 percent of the stock of its intended M&A target Alterra, according to the latest Securities and Exchange Commission filing relating to the proposed deal.